
|Videos|May 6, 2021
Looking at real-world trial data replication outcomes of IRIS Registry data
Author(s)OT Staff Reports, David Hutton
Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Advertisement
Theodore Leng, MD, medical advisor at Verana Health and director of clinical translational research, Byers Eye Institute, Stanford University School of Medicine, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," in which the first replications using real-world data of a phase 3 trial was utilized, during the virtual 2021 ARVO meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
3
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
4
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
5


























